Boodai Shurooq A, Cherry Lynne M, Sattar Naveed A, Reilly John J
University of Glasgow School of Medicine, Yorkhill Hospitals, Glasgow, Scotland.
Institute of Cardiovascular and Medical Sciences, British Heart Foundation Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, Scotland.
Diabetes Metab Syndr Obes. 2014 Oct 24;7:505-11. doi: 10.2147/DMSO.S66156. eCollection 2014.
Childhood and adolescent obesity is associated with insulin resistance, abnormal glucose metabolism, hypertension, dyslipidemia, inflammation, liver disease, and compromised vascular function. The purpose of this pilot study was to determine the prevalence of cardiometabolic risk factor abnormalities and metabolic syndrome (MetS) in a sample of obese Kuwaiti adolescents, as prevalence data might be helpful in improving engagement with obesity treatment in future.
Eighty obese Kuwaiti adolescents (40 males) with a mean (standard deviation) age of 12.3 years (1.1 years) participated in the present study. All participants had a detailed clinical examination and anthropometry, blood pressure taken, and assessment of fasting levels of C-reactive protein, intracellular adhesion molecule, interleukin-6, fasting blood glucose, insulin, liver function tests (alanine aminotransferase, aspartate aminotransferase, gamma glutamyltransferase), lipid profile (cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglycerides), insulin resistance by homeostasis model assessment, and adiponectin. MetS was assessed using two recognized criteria modified for use in younger individuals.
The cardiometabolic risk factors with highest prevalence of abnormal values included aspartate aminotransferase (88.7% of the sample) and insulin resistance by homeostasis model assessment (67.5%), intracellular adhesion molecule (66.5%), fasting insulin (43.5%), C-reactive protein (42.5%), low-density lipoprotein cholesterol (35.0%), total cholesterol (33.5%), and systolic blood pressure (30.0%). Of all participants, 96.3% (77/80) had at least one impaired cardiometabolic risk factor as well as obesity. Prevalence of MetS was 21.3% according to the International Diabetes Federation definition and 30% using the Third Adult Treatment Panel definition.
The present study suggests that obese Kuwaiti adolescents have multiple cardiometabolic risk factor abnormalities. Future studies are needed to test the benefits of intervention in this high-risk group. They also suggest that prevention of obesity in children and adults should be a major public health goal in Kuwait.
儿童和青少年肥胖与胰岛素抵抗、葡萄糖代谢异常、高血压、血脂异常、炎症、肝脏疾病以及血管功能受损有关。这项初步研究的目的是确定科威特肥胖青少年样本中心血管代谢危险因素异常和代谢综合征(MetS)的患病率,因为患病率数据可能有助于未来提高肥胖治疗的参与度。
八十名科威特肥胖青少年(40名男性)参与了本研究,平均(标准差)年龄为12.3岁(1.1岁)。所有参与者均接受了详细的临床检查和人体测量、测量血压,并评估了空腹C反应蛋白、细胞间黏附分子、白细胞介素-6、空腹血糖、胰岛素、肝功能检查(丙氨酸转氨酶、天冬氨酸转氨酶、γ-谷氨酰转移酶)、血脂谱(胆固醇、低密度脂蛋白胆固醇、高密度脂蛋白胆固醇、甘油三酯)、通过稳态模型评估的胰岛素抵抗以及脂联素。使用两种针对年轻个体修改的公认标准评估MetS。
异常值患病率最高的心血管代谢危险因素包括天冬氨酸转氨酶(样本的88.7%)、通过稳态模型评估的胰岛素抵抗(67.5%)、细胞间黏附分子(66.5%)、空腹胰岛素(43.5%)、C反应蛋白(42.5%)、低密度脂蛋白胆固醇(35.0%)、总胆固醇(33.5%)和收缩压(30.0%)。在所有参与者中,96.3%(77/80)至少有一项心血管代谢危险因素受损以及肥胖。根据国际糖尿病联盟的定义,MetS的患病率为21.3%,使用第三次成人治疗小组定义为30%。
本研究表明,科威特肥胖青少年存在多种心血管代谢危险因素异常。未来需要进行研究以测试对这一高危群体进行干预的益处。研究还表明,预防儿童和成人肥胖应成为科威特的一项主要公共卫生目标。